Literature DB >> 28944524

Changes of vitamin D levels and bone turnover markers after CPAP therapy: a randomized sham-controlled trial.

Jenny Theorell-Haglöw1,2, Camilla M Hoyos1, Craig L Phillips1, Brendon J Yee1, Markus Herrmann3, Tara C Brennan-Speranza4, Ronald R Grunstein1, Peter Y Liu5.   

Abstract

The aim was to investigate whether continuous positive airway pressure treatment could modulate serum vitamin D (25-hydroxyvitamin D) and bone turnover markers (collagen-type 1 cross-linked C-telopeptide, osteocalcin and N-terminal propeptide of type 1 collagen) in secondary analysis from a randomized controlled trial. Sixty-five continuous positive airway pressure-naïve male patients with obstructive sleep apnea (age = 49 ± 12 years, apnea-hypopnea index = 39.9 ± 17.7 events h-1 , body mass index = 31.3 ± 5.2 kg m-2 ) were randomized to receive either real (n = 34) or sham (n = 31) continuous positive airway pressure for 12 weeks. At 12 weeks, all participants received real continuous positive airway pressure for an additional 12 weeks. After 12 weeks of continuous positive airway pressure (real versus sham), there were no between-group differences for any of the main outcomes [Δ25-hydroxyvitamin D: -0.80 ± 5.28 ng mL-1 (mean ± SE) versus 3.08 ± 3.66 ng mL-1 , P = 0.42; Δcollagen-type 1 cross-linked C-telopeptide: 0.011 ± 0.014 ng mL-1 versus -0.004 ± 0.009 ng mL-1 , P = 0.48; Δosteocalcin: 1.13 ± 1.12 ng mL-1 versus 0.46 ± 0.75 ng mL-1 , P = 0.80; ΔN-terminal propeptide of type 1 collagen: 2.07 ± 3.05 μg L-1 versus -1.05 ± 2.13 μg L-1 , P = 0.48]. There were no further differences in subgroup analyses (continuous positive airway pressure-compliant patients, patients with severe obstructive sleep apnea or sleepy patients). However, after 24 weeks irrespective of initial randomization, vitamin D increased in patients with severe obstructive sleep apnea (9.56 ± 5.51 ng mL-1 , P = 0.045) and in sleepy patients (14.0 ± 4.69 ng mL-1 , P = 0.007). Also, there was a significant increase in osteocalcin at 24 weeks (3.27 ± 1.06 ng mL-1 , P = 0.01) in compliant patients. We conclude that 12 weeks of continuous positive airway pressure did not modulate vitamin D or modulate any of the bone turnover markers compared with sham. However, it is plausible that continuous positive airway pressure may have late beneficial effects on vitamin D levels and bone turnover markers in selected groups of patients with obstructive sleep apnea.
© 2017 European Sleep Research Society.

Entities:  

Keywords:  bone turnover markers; continuous positive airway pressure therapy; obstructive sleep apnea; randomized controlled trial; vitamin D

Mesh:

Substances:

Year:  2017        PMID: 28944524     DOI: 10.1111/jsr.12606

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  4 in total

1.  Obstructive Sleep Apnea and Risk for Incident Vertebral and Hip Fracture in Women.

Authors:  Tianyi Huang; Shelley S Tworoger; Susan Redline; Gary C Curhan; Julie M Paik
Journal:  J Bone Miner Res       Date:  2020-09-09       Impact factor: 6.741

Review 2.  Interactions between and Shared Molecular Mechanisms of Diabetic Peripheral Neuropathy and Obstructive Sleep Apnea in Type 2 Diabetes Patients.

Authors:  Hong Shen; Junrong Zhao; Ying Liu; Guangdong Sun
Journal:  J Diabetes Res       Date:  2018-07-19       Impact factor: 4.011

Review 3.  The role of vitamin D in obstructive sleep apnoea syndrome.

Authors:  Kostas Archontogeorgis; Evangelia Nena; Nikolaos Papanas; Paschalis Steiropoulos
Journal:  Breathe (Sheff)       Date:  2018-09

4.  Sleep duration as an independent factor associated with vitamin D levels in the EPISONO cohort.

Authors:  Daniela Leite de Oliveira; Vinícius Dokkedal-Silva; Guilherme Luiz Fernandes; Lenise Jihe Kim; Sergio Tufik; Monica Levy Andersen
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.062

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.